Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 74.12 CNY -2.86%
Market Cap: 93.8B CNY
Have any thoughts about
Beijing Wantai Biological Pharmacy Enterprise Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Wall Street analysts forecast Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 62.63 CNY with a low forecast of 48.99 CNY and a high forecast of 78.02 CNY.

Lowest
Price Target
48.99 CNY
34% Downside
Average
Price Target
62.63 CNY
16% Downside
Highest
Price Target
78.02 CNY
5% Upside
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors:
Price Targets
688373
Shanghai MicuRx Pharmaceutical Co Ltd
26% Upside
ALNY
Alnylam Pharmaceuticals Inc
26% Upside
SPRO
Spero Therapeutics Inc
434% Upside
PTCT
PTC Therapeutics Inc
2% Upside
2160
GNI Group Ltd
22% Upside
SRPT
Sarepta Therapeutics Inc
58% Upside
CYTK
Cytokinetics Inc
74% Upside
MDGL
Madrigal Pharmaceuticals Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 22%.

41%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 15%.

55%
Past Growth
15%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 38%.

34%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
62.63 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 62.63 CNY with a low forecast of 48.99 CNY and a high forecast of 78.02 CNY.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 22%.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 15%.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
38%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 3 years is 38%.

Back to Top